Lucas E. Cavallin, Ph.D. - Publications

Affiliations: 
2010 University of Miami, Coral Gables, FL 
Area:
Oncology

15 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Medina MV, D Agostino A, Ma Q, Eroles P, Cavallin L, Chiozzini C, Sapochnik D, Cymeryng C, Hyjek E, Cesarman E, Naipauer J, Mesri EA, Coso OA. KSHV G-protein coupled receptor vGPCR oncogenic signaling upregulation of Cyclooxygenase-2 expression mediates angiogenesis and tumorigenesis in Kaposi's sarcoma. Plos Pathogens. 16: e1009006. PMID 33057440 DOI: 10.1371/journal.ppat.1009006  0.696
2019 Naipauer J, Cavallin LE, Mesri EA. Unbiased Screening of Activated Receptor Tyrosine Kinases (RTKs) in Tumor Extracts Using a Mouse Phospho-RTK Array Kit. Bio-Protocol. 9. PMID 32864391 DOI: 10.21769/bioprotoc.3216  0.699
2019 Naipauer J, Cavallin L, Mesri E. Unbiased Screening of Activated Receptor Tyrosine Kinases (RTKs) in Tumor Extracts Using a Mouse Phospho-RTK Array Kit Bio-Protocol. 9. DOI: 10.21769/bioprotoc.3216  0.624
2018 Cavallin LE, Ma Q, Naipauer J, Gupta S, Kurian M, Locatelli P, Romanelli P, Nadji M, Goldschmidt-Clermont PJ, Mesri EA. KSHV-induced ligand mediated activation of PDGF receptor-alpha drives Kaposi's sarcomagenesis. Plos Pathogens. 14: e1007175. PMID 29985958 DOI: 10.1371/Journal.Ppat.1007175  0.732
2014 Cavallin LE, Goldschmidt-Clermont P, Mesri EA. Molecular and cellular mechanisms of KSHV oncogenesis of Kaposi's sarcoma associated with HIV/AIDS. Plos Pathogens. 10: e1004154. PMID 25010730 DOI: 10.1371/Journal.Ppat.1004154  0.642
2013 Mesri EA, Cavallin LE, Ashlock BM, Leung HJ, Ma Q, Goldschmidt-Clermont PJ. Molecular studies and therapeutic targeting of Kaposi's sarcoma herpesvirus (KSHV/HHV-8) oncogenesis. Immunologic Research. 57: 159-65. PMID 24203444 DOI: 10.1007/S12026-013-8458-Z  0.709
2013 Ma Q, Cavallin LE, Leung HJ, Chiozzini C, Goldschmidt-Clermont PJ, Mesri EA. A role for virally induced reactive oxygen species in Kaposi's sarcoma herpesvirus tumorigenesis. Antioxidants & Redox Signaling. 18: 80-90. PMID 22746102 DOI: 10.1089/Ars.2012.4584  0.696
2012 Croci DO, Salatino M, Rubinstein N, Cerliani JP, Cavallin LE, Leung HJ, Ouyang J, Ilarregui JM, Toscano MA, Domaica CI, Croci MC, Shipp MA, Mesri EA, Albini A, Rabinovich GA. Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma. The Journal of Experimental Medicine. 209: 1985-2000. PMID 23027923 DOI: 10.1084/Jem.20111665  0.707
2011 Cavallin LE, Ma Q, Goldschmidt-Clermont PJ, Mesri EA. Abstract 2710: KSHV-induced PDGF signaling dyregulation drives a Rac1 and ROS-mediated paracrine tumorigenic mechanism necessary for Kaposi's sarcoma Cancer Research. 71: 2710-2710. DOI: 10.1158/1538-7445.Am2011-2710  0.739
2010 Sarosiek KA, Cavallin LE, Bhatt S, Toomey NL, Natkunam Y, Blasini W, Gentles AJ, Ramos JC, Mesri EA, Lossos IS. Efficacy of bortezomib in a direct xenograft model of primary effusion lymphoma. Proceedings of the National Academy of Sciences of the United States of America. 107: 13069-74. PMID 20615981 DOI: 10.1073/Pnas.1002985107  0.701
2010 Cavallin LE, Ma Q, Goldschmidt-Clermont P, Mesri EA. KSHV-mediated ROS induction defines novel therapeutic targets in Kaposi's sarcoma Infectious Agents and Cancer. 5. DOI: 10.1186/1750-9378-5-S1-A49  0.745
2009 Muratori C, Cavallin LE, Krätzel K, Tinari A, De Milito A, Fais S, D'Aloja P, Federico M, Vullo V, Fomina A, Mesri EA, Superti F, Baur AS. Massive secretion by T cells is caused by HIV Nef in infected cells and by Nef transfer to bystander cells. Cell Host & Microbe. 6: 218-30. PMID 19748464 DOI: 10.1016/J.Chom.2009.06.009  0.66
2009 Ma Q, Cavallin LE, Yan B, Zhu S, Duran EM, Wang H, Hale LP, Dong C, Cesarman E, Mesri EA, Goldschmidt-Clermont PJ. Antitumorigenesis of antioxidants in a transgenic Rac1 model of Kaposi's sarcoma. Proceedings of the National Academy of Sciences of the United States of America. 106: 8683-8. PMID 19429708 DOI: 10.1073/Pnas.0812688106  0.743
2007 Mutlu AD, Cavallin LE, Vincent L, Chiozzini C, Eroles P, Duran EM, Asgari Z, Hooper AT, La Perle KM, Hilsher C, Gao SJ, Dittmer DP, Rafii S, Mesri EA. In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: a cell and animal model of virally induced Kaposi's sarcoma. Cancer Cell. 11: 245-58. PMID 17349582 DOI: 10.1016/J.Ccr.2007.01.015  0.708
2007 D'Agostino Mutlu A, Cavallin LE, Vincent L, Chiozzini C, Eroles P, Duran EM, Asgari Z, Hooper AT, La Perle KMD, Hilsher C, Gao SJ, Dittmer DP, Rafii S, Mesri EA. In Vivo-Restricted and Reversible Malignancy Induced by Human Herpesvirus-8 KSHV: A Cell and Animal Model of Virally Induced Kaposi's Sarcoma (DOI:10.1016/j.ccr.2007.01.015) Cancer Cell. 11: 471. DOI: 10.1016/J.Ccr.2007.04.013  0.691
Show low-probability matches.